retatrutide effects clinical trial Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 Retatrutide Weight Loss Treatment Explained

Which hormone does exendin-4 closely resemble

At 12mg (the highest dose), participants lost 24.2% of body weight on average

More details here: medicalxpress.com/news/2026-04-a And full paper published in Nature: nature.com/articles/s4436 Concerning because of how gameable it just became

Choosing to purchase from reputable sources ensures safety and helps users achieve their weight-loss goals effectively and securely

& Walsh, K

The WHO guidelines call for urgent action on manufacturing, affordability, and system readiness, recommending strategies such as pooled procurement, tiered pricing, and voluntary licensing to expand global access [51]